Longboard Pharmaceuticals (LBPH) Earnings Date, Estimates & Call Transcripts

$19.35
-0.40 (-2.03%)
(As of 03:34 PM ET)

Earnings Summary

Upcoming
Earnings Date
May. 14Estimated
Actual EPS
(Mar. 12)
-$0.62 Missed By -$0.02
Consensus EPS
(Mar. 12)
-$0.60
Skip Charts & View Estimated and Actual Earnings Data

LBPH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LBPH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Longboard Pharmaceuticals Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20243($0.56)($0.37)($0.47)
Q2 20243($0.55)($0.37)($0.46)
Q3 20243($0.62)($0.39)($0.50)
Q4 20243($0.66)($0.39)($0.53)
FY 202412($2.39)($1.52)($1.96)
Q1 20251($0.57)($0.57)($0.57)
Q2 20251($0.59)($0.59)($0.59)
Q3 20251($0.62)($0.62)($0.62)
Q4 20251($0.64)($0.64)($0.64)
FY 20254($2.42)($2.42)($2.42)

LBPH Earnings Date and Information

Longboard Pharmaceuticals last released its earnings results on March 12th, 2024. The reported ($0.62) earnings per share for the quarter, missing analysts' consensus estimates of ($0.60) by $0.02. Longboard Pharmaceuticals has generated ($2.38) earnings per share over the last year (($2.38) diluted earnings per share). Earnings for Longboard Pharmaceuticals are expected to decrease in the coming year, from ($2.01) to ($2.47) per share. Longboard Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off prior year's report dates.

Longboard Pharmaceuticals Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/14/2024
Estimated)
------- 
3/12/2024Q4 2023($0.60)($0.62)($0.02)($0.62)--
11/2/2023Q3 2023($0.72)($0.55)+$0.17($0.55)--
8/3/2023Q2 2023($0.61)($0.65)($0.04)($0.65)--
5/9/2023Q1 2023($0.59)($0.56)+$0.03($0.56)--
3/2/2023Q4 2022($0.63)($0.66)($0.03)($0.66)--
11/3/2022Q3 2022($0.51)($0.68)($0.17)($0.68)--
8/4/2022Q2 2022($0.54)($0.67)($0.13)($0.67)--
5/5/2022Q1 2022($0.52)($0.56)($0.04)($0.56)--
3/3/2022Q4 2021($0.41)($0.52)($0.11)($0.52)--
11/4/2021Q3 2021($0.48)($0.38)+$0.10($0.38)--
8/9/2021Q2 2021($0.67)($0.41)+$0.26($0.41)--
5/10/2021Q1 2021-($0.84)($0.84)($0.84)--

Longboard Pharmaceuticals Earnings - Frequently Asked Questions

When is Longboard Pharmaceuticals's earnings date?

Longboard Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 14th, 2024 based off last year's report dates. Learn more on LBPH's earnings history.

Did Longboard Pharmaceuticals beat their earnings estimates last quarter?

In the previous quarter, Longboard Pharmaceuticals (NASDAQ:LBPH) missed the analysts' consensus estimate of ($0.60) by $0.02 with a reported earnings per share (EPS) of ($0.62). Learn more on analysts' earnings estimate vs. LBPH's actual earnings.

How much profit does Longboard Pharmaceuticals generate each year?

Longboard Pharmaceuticals (NASDAQ:LBPH) has a recorded net income of -$54.42 million. LBPH has generated -$2.38 earnings per share over the last four quarters.

What is Longboard Pharmaceuticals's EPS forecast for next year?

Longboard Pharmaceuticals's earnings are expected to decrease from ($2.01) per share to ($2.47) per share in the next year.


More Earnings Resources from MarketBeat

This page (NASDAQ:LBPH) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners